MS Advanced Practice Providers

The NeurologyLive® multiple sclerosis (MS) Advanced Practice Providers (APPs) clinical focus page is a concentrated place for the latest information on the care and management of patients with MS, including relapsing MS and progressive MS, as well as related and demyelinating disorders such as neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. This page includes podcasts, videos and expert interviews, and news about the latest study and clinical trial findings, FDA actions, and clinical guideline updates.

Latest News

NeuroVoices: David A. Hafler, MD, FANA, on Evolving the MS Diagnostic Criteria to Enhance Precision for Earlier and More Effective Care
NeuroVoices: David A. Hafler, MD, FANA, on Evolving the MS Diagnostic Criteria to Enhance Precision for Earlier and More Effective Care

November 13th 2024

The William S. and Lois Stiles Edgerly Professor of Neurology at Yale School of Medicine discussed the newly updated multiple sclerosis criteria, highlighting their focus on probabilistic assessment, advanced technology integration, and early intervention to improve patient care.

Therapeutic Potential of Neuroimmune Modulation in Treatment Paradigm of Relapsing Multiple Sclerosis
Therapeutic Potential of Neuroimmune Modulation in Treatment Paradigm of Relapsing Multiple Sclerosis

November 9th 2024

NeuroVoices: Wallace Brownlee, MBChB, PhD, FRACP, on Moving Toward a Unified, Biology-Driven Approach in the New Diagnostic Criteria for MS
NeuroVoices: Wallace Brownlee, MBChB, PhD, FRACP, on Moving Toward a Unified, Biology-Driven Approach in the New Diagnostic Criteria for MS

September 25th 2024

NeuroVoices: Antonio Scalfari, MD, PhD, on a Broader Perspective of Understanding Smoldering Disease in Multiple Sclerosis Progression
NeuroVoices: Antonio Scalfari, MD, PhD, on a Broader Perspective of Understanding Smoldering Disease in Multiple Sclerosis Progression

September 18th 2024

Imbalances in Sex Ratio, Mean Onset of NMOSD Related to AQP4 Positivity and Population Life Expectancy
Imbalances in Sex Ratio, Mean Onset of NMOSD Related to AQP4 Positivity and Population Life Expectancy

August 30th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.